Horizon Technology Finance to Announce Second Quarter 2019 Financial Results

FARMINGTON, Conn., July 16, 2019 /PRNewswire/ — Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”) (the “Company”), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today that it plans to release financial results for the second quarter ended June 30, 2019 on Tuesday, July 30, 2019, after the close of market trading.  

The Company has scheduled a conference call to discuss the results on Wednesday, July 31, 2019, at 9:00 a.m. ET. The conference call will feature remarks by Robert D. Pomeroy, Jr., Chairman and Chief Executive Officer, Gerald A. Michaud, President, and Daniel R. Trolio, Senior Vice President and Chief Financial Officer. To participate in the call, please dial (877) 407-9716 (domestic) or (201) 493-6779 (international). The conference ID is 13692493. Please dial into the call at least five minutes before the scheduled start time.

The conference call will also be available via a live listen-only webcast on the Company’s website, www.horizontechfinance.com. Please allow extra time prior to the call to visit the site and download any necessary software that may be needed to listen to the Internet broadcast.

For interested individuals unable to join the live conference call, a replay of the call will be available through August 1, 2019 at (844) 512-2921 (domestic) or (412) 317-6671 (international). The conference ID is 13692493. An online archive of the webcast will be available on the Company’s website for 30 days following the call.

About Horizon Technology Finance

Horizon Technology Finance Corporation (NASDAQ: HRZN) is a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries. The investment objective of Horizon is to maximize its investment portfolio’s return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. Headquartered in Farmington, Connecticut, Horizon also has regional offices in Pleasanton, California, Reston, Virginia and Boston, Massachusetts. To learn more, please visit www.horizontechfinance.com.

Forward-Looking Statements

Statements included herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in the Company’s filings with the Securities and Exchange Commission. Horizon undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

Contacts:

Investor Relations:
ICR
Garrett Edson
ir@horizontechfinance.com 
(860) 284-6450

Media Relations:
ICR
Brian Ruby
brian.ruby@icrinc.com 
(203) 682-8268

View original content:http://www.prnewswire.com/news-releases/horizon-technology-finance-to-announce-second-quarter-2019-financial-results-300885805.html

SOURCE Horizon Technology Finance Corporation

Staff

Recent Posts

Red Light Holland’s Partner FDA-Compliant and DEA-Registered Irvine Labs Receives 2025 Psilocybin DEA Quotas, Including Import Quota

The companies are now moving forward with the import permit application process.Following expected approval of…

27 minutes ago

Psyence BioMed Announces USD$500,000 Follow-On Investment in PsyLabs and Global Ibogaine Supply Agreement

New York, New York--(Newsfile Corp. - April 15, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM)…

27 minutes ago

Ezra Appoints Dr. Danna Chung as Chief Medical Officer

Dr. Chung brings expertise in scaling medical teams to Ezra’s mission of making early cancer…

27 minutes ago

NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1×1 Meetings on Thursday, April 24, 2025

CARMEL, Ind., April 15, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE…

28 minutes ago

LiveWorld Releases First-Ever AI Brand Reputation Index for Leading Pharmaceutical Brands

Study Highlights Critical Influence of AI-Driven Reputation on Pharma Market Leaders and New EntrantsCAMPBELL, Calif.…

28 minutes ago